South Dakota Investment Council Bristol Myers Squibb CO Transaction History

South Dakota Investment Council

$5.22 Billion
Q2 2025

A detailed history of South Dakota Investment Council transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, South Dakota Investment Council holds 431,279 shares of BMY stock, worth $19.9 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

431,279

Previous 431,279 -0.0%

Holding current value

$19.9 Million

Previous $26.3 Million 24.1%

% of portfolio

0.38%

Previous 0.54%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	BUY	$53.9 - $63.11 $204,119 - $238,997	3,787 Added 0.89%	431,279 $26.3 Million
Q3 2024 Nov 04, 2024	BUY	$39.66 - $51.75 $3.44 Million - $4.48 Million	86,627 Added 25.41%	427,492 $22.1 Million
Q2 2024 Aug 08, 2024	BUY	$40.25 - $52.99 $1.87 Million - $2.47 Million	46,564 Added 15.82%	340,865 $14.2 Million
Q1 2024 May 02, 2024	BUY	$47.98 - $54.4 $5.85 Million - $6.63 Million	121,926 Added 70.73%	294,301 $16 Million
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $271,488 - $323,960	-5,600 Reduced 3.15%	172,375 $8.85 Million
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $2.08 Million - $2.32 Million	35,858 Added 25.23%	177,975 $10.3 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $203,872 - $226,367	-3,200 Reduced 2.2%	142,117 $9.09 Million
Q4 2022 Feb 07, 2023	SELL	$68.48 - $81.09 $280,768 - $332,469	-4,100 Reduced 2.74%	145,317 $10.5 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $6,880 - $4.07 Million	-52,926 Reduced 26.16%	149,417 $10.6 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $7.74 Million - $8.52 Million	-106,536 Reduced 34.49%	202,343 $15.6 Million
Q1 2022 May 10, 2022	SELL	$61.48 - $73.72 $10.6 Million - $12.7 Million	-172,044 Reduced 35.77%	308,879 $22.6 Million
Q4 2021 Feb 08, 2022	BUY	$53.63 - $62.52 $2.23 Million - $2.6 Million	41,570 Added 9.46%	480,923 $30 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $473,360 - $554,480	8,000 Added 1.85%	439,353 $26 Million
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $4.17 Million - $4.54 Million	-67,290 Reduced 13.49%	431,353 $28.8 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $1.71 Million - $1.92 Million	28,788 Added 6.13%	498,643 $31.5 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $1.03 Million - $1.17 Million	17,900 Added 3.96%	469,855 $29.1 Million
Q3 2020 Nov 06, 2020	BUY	$57.43 - $63.64 $387,078 - $428,933	6,740 Added 1.51%	451,955 $27.2 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $302,606 - $353,776	-5,520 Reduced 1.22%	445,215 $26.2 Million
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $4.83 Million - $7.02 Million	-104,080 Reduced 18.76%	450,735 $25.1 Million
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $9.63 Million - $12.6 Million	195,655 Added 54.48%	554,815 $35.6 Million
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $675,338 - $800,710	-15,790 Reduced 4.21%	359,160 $18.2 Million
Q2 2019 Aug 13, 2019	SELL	$44.62 - $49.34 $7.35 Million - $8.13 Million	-164,730 Reduced 30.52%	374,950 $17 Million
Q1 2019 May 03, 2019	BUY	$45.12 - $53.8 $13.8 Million - $16.4 Million	304,910 Added 129.88%	539,680 $25.7 Million
Q4 2018 Feb 06, 2019	BUY	$48.76 - $63.23 $71,677 - $92,948	1,470 Added 0.63%	234,770 $12.2 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $1.07 Million - $1.2 Million	-19,300 Reduced 7.64%	233,300 $14.5 Million
Q2 2018 Aug 13, 2018	BUY	$50.53 - $62.98 $8.35 Million - $10.4 Million	165,300 Added 189.35%	252,600 $14 Million
Q4 2017 Feb 09, 2018	SELL	$59.94 - $65.35 $857,142 - $934,504	-14,300 Reduced 14.07%	87,300 $5.35 Million
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $5.61 Million - $6.48 Million	101,600	101,600 $6.48 Million

Others Institutions Holding BMY

# of Institutions

2,668

Shares Held

1.64B

Call Options Held

22.5M

Put Options Held

25.3M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $98B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.

Account

South Dakota Investment Council Bristol Myers Squibb CO Transaction History